ICU Cell Saver to Reduce Blood Transfusions in Cardiac

Cardiochirurgia E.H.

Status: Completed

Conditions: Cardiac Surgery; Blood Transfusion

Treatments: Device: Traditional Chest Drains; Device: CARDIOPAT

Study type: Interventional

Funder types: Other

Identifiers

NCT00950547

00-02

Details and patient eligibility

About

PURPOSE: Autotransfusion devices may be employed in cardiac surgery to decrease allogenic blood requirements. Limitations of previous trials include the use of cell saver systems in selected high risk patients only or the lack of blood transfusion-sparing strategies. The aim of this prospective randomized study is to evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery.

METHODS: The investigators will randomize 350 patients in two groups: group 1 receives a CardioPAT cell saver device (175 patients), group 2 doesn't receive any cell saver device. The incidence of allogenic blood transfusion and clinical outcome in both groups are evaluated.

Enrollment: 350 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients presenting for cardiac Surgery

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

350 participants in 2 patient groups

Control

Active Comparator group

Description:

Traditional Chest drains

Treatment:

Device: Traditional Chest Drains

CARDIOPAT

Experimental group

Description:

CARDIOPAT Cell Saver after Surgery

Treatment:

Device: CARDIOPAT